Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIVIR: Oseltamivir and Zanamivir Combination Therapy for Influenza A
NCT00799760Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oseltamivir, zanamivir in Influenza A (IAV), sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2008; status: terminated.
02
Drugs
oseltamivirzanamivir
03
Conditions
Influenza A (IAV)
Beyond the preview
Go deeper on NCT00799760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00799760.